Skip to main content
Log in

Diagnostic nuclear medicine and risk for the fetus

  • Occasional survey
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract.

The possible detrimental effects on the developing embryo subsequent to irradiation are discussed. The doses to the embryo or fetus encountered for the most common procedures in diagnostic nuclear medicine are evaluated with respect to the threshold doses and the risks per cGy. The threshold dose for fatal and non-fatal malformations or other defects is, at the lowest estimate, 5–10 cGy. The dose which the embryo or fetus receives from diagnostic nuclear medicine is below 1 cGy. For the induction of fatal cancer and for genetic defects no threshold dose is assumed. The risk for the induction of cancer is 0.03%–0.05% per cGy. The risk for the induction of genetic defects is even lower (0.024%–0.099% per cGy). It is concluded that for common diagnostic nuclear medicine procedures the risk of detrimental effects on the embryo or fetus due to radiation is negligible. On the basis of present knowledge there are no radiation safety indications for abortus provocatus as a consequence of a diagnostic nuclear medicine study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steenvoorde, P., Pauwels, E., Harding, L. et al. Diagnostic nuclear medicine and risk for the fetus. Eur J Nucl Med 25, 193–199 (1998). https://doi.org/10.1007/s002590050215

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002590050215

Navigation